Mortality Outcome of Controlled Hypertension (NCT07187596) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Mortality Outcome of Controlled Hypertension
Thailand2,547 participantsStarted 2025-09-18
Plain-language summary
This review focuses on the assumption of mortality outcome of participants remaining label hypertension care is adequately managed when pressure targets are met with both qualitative and quantitaive method.
Who can participate
Age range
1 Minute – 130 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
* Inclusion:
* Human birth in all sex chromosomes.
* Study reports evidence of living with owned systemic/arterial hypertension by one of definition following;
* Quantitative: Blood pressure number higher over the normal range by each protocol in mmHg unit in any arm of study.
* Qualitative: Clarify the underwent both retrospective, observation or intervention of blood pressure and clearly clarify number of hypertension participants in article.
* Study design: any type of studies and have a doi number.
* In case report type study, the article recruit in only high blood pressure is a burden that reports both direct intervention for blood pressure or indirect intervention such as treatment of vascular damage from high blood pressure.
* In a group of literature review type study, the number of hypertension participants with references from both in supplementary document or traced back via each doi number have to clearly declare in that free full-text and currently non-retracted article without personal requirement as raw material to processing the individual participant data meta-analysis
* Study recruit only last version of study series that have to confirm published the hypertension participant with mortality outcomes.
* English-language studies.
* Exclusion:
* Non human/human-specimen studies.
* Evidence confirms local site or specific system hypertension only such as studies of pulmonary hypertension, portal hypertension, ocular hypertension…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this study is actively collecting data but no longer enrolling new participants, is there any chance I could still be considered, or are there similar ongoing studies on controlled hypertension and vascular mortality that I might be eligible for?
2This trial is measuring all-cause vascular mortality across serious conditions like stroke, arterial aneurysm, and renal disease — what does that tell us about how my own blood pressure control might affect my long-term risk for these outcomes?
3The trial covers a wide range of hypertension-related complications including pre-eclampsia and arterial rupture — given my specific situation, which of these complications should we be most focused on monitoring or preventing?
4Since this study is listed as Phase NA, which often means it's observational rather than testing a new treatment, does participating in or following the findings of a study like this actually change the treatment options available to me, or would standard hypertension management still be the recommended path?
5Once results from this study on vascular mortality and controlled hypertension become available, how might those findings influence the blood pressure targets or medications my care team recommends for me?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
All-cause vascular mortality
Timeframe: Day one until last follow up at least 24 hour to study completion date at least 30 days outcomes but not over 10 years